Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

I've scanned the report. I plan to go through it in detail and provide further analysis, but here are my initial thoughts:

Overall, the report looks great to me. It doesn't throw out any shocking negative surprises that I can see, it confirms much of what we already suspected, and it provides some new insights... all of which I was hoping to see... I'm pleased.

As for the Swiss sell off, I've scanned their message boards. Now, I'm no accountant or financial expert, but it looks like some of the Swiss may have seen the Aviptadil valuation as an indicator of Relief's forecast of total expected future revenues from Aviptadil. This would be incorrect, as the value assigned to Aviptadil is an "accounting" value used for depreciation and taxation purposes, and does not necessarily represent the true worth of the asset and all its forecasted revenues (especially since they cannot account for FDA approval yet)... someone please correct me if I'm wrong. It looks like some of the Swiss are starting to catch on to their incorrect assessment, and thus the stock price is drifting back up. I'll take a closer look at this, but wanted to give everyone some direction for their own investigation.

(The above comments are my opinion. I am not an expert and these are my layman assessments. As usual, my comments are not to be considered investment advice.)